Mina J. Bissell | |
---|---|
Born | |
Nationality | Iranian-American |
Alma mater | Harvard Medical School, University of California, Berkeley |
Known for | cancer research |
Awards | Ernest Orlando Lawrence Award, Guggenheim Fellowship |
Scientific career | |
Fields | Biology |
Mina J. Bissell is an Iranian-American biologist known for her research on breast cancer. In particular, she has studied the effects of a cell's microenvironment, including its extracellular matrix, on tissue function. [1]
Bissell was born in Tehran, Iran and brought up in an educated and wealthy family. By the time she graduated from high school, Bissell was the top graduate in her year in Iran. [2] A family friend, through the American Friends of Iran, encouraged Bissell to come to the United States. [2] She enrolled at Bryn Mawr, then transferred to Radcliffe College where she earned a bachelor's degree in chemistry. She obtained a PhD in bacteriology from Harvard Medical School (1969) and was awarded an American Cancer Society postdoctoral fellowship at the University of California, Berkeley. [3]
She joined the Lawrence Berkeley Laboratory as a staff biochemist in 1972 and subsequently became a Senior Scientist, Director of Cell & Molecular Biology, Director of the Life Sciences Division, and Distinguished Scientist. [4] In 1996, she received the Ernest Orlando Lawrence Award and medal, the highest scientific honor bestowed by the United States Department of Energy. A member of the American Academy of Arts and Sciences, the Institute of Medicine, and the American Philosophical Society, [5] Bissell is a recipient of the Guggenheim Fellowship, the Mellon Award from the University of Pittsburgh, the Eli Lilly/Clowes Award of the American Association for Cancer Research, and the Medal of Honor from the American Cancer Society. [4] She was elected to the National Academy of Sciences in 2010, one of the highest honors bestowed on working scientists. In 2016, the American Society for Cell Biology will bestow the E.B. Wilson Medal, its highest scientific honor, to Dr. Bissell for her work showing that physical context matters in cells and her demonstrations that the extracellular matrix (ECM) is integral to breast tissue remodeling and to breast cancer progression. In 2020 she received the Canada Gairdner International Award. [6]
She is the former head of life sciences at Lawrence Berkeley Laboratory. Her work started over 30 years ago on the effect of tissue architecture and the role of the cellular microenvironment on cancer still has become increasingly influential in the field of cancer biology and cancer therapeutics. She is credited with the radical but increasingly accepted notion that phenotype can dominate over genotype in normal development and disease. [7]
Bissell and her colleague, William Ole Peterson, have developed 3D culture in cancer research. They have shown non-tumorgenic (normal-like) mammary epithelial cells form monolayer spherical acini with hollow lumen and tumorgenic mammary epithelial cells form filled bowl irregular acini. [8] She has published about 300 articles and book chapters. [9]
In June 2012 she presented at the TED conference. On Cancer Day 2013, this talk was featured as the first talk in a series of ten talks about cancer presented by TED. [10] [11]
Morphogenesis is the biological process that causes a cell, tissue or organism to develop its shape. It is one of three fundamental aspects of developmental biology along with the control of tissue growth and patterning of cellular differentiation.
A mammary gland is an exocrine gland in humans and other mammals that produces milk to feed young offspring. Mammals get their name from the Latin word mamma, "breast". The mammary glands are arranged in organs such as the breasts in primates, the udder in ruminants, and the dugs of other animals. Lactorrhea, the occasional production of milk by the glands, can occur in any mammal, but in most mammals, lactation, the production of enough milk for nursing, occurs only in phenotypic females who have gestated in recent months or years. It is directed by hormonal guidance from sex steroids. In a few mammalian species, male lactation can occur. With humans, male lactation can occur only under specific circumstances.
MCF-7 is a breast cancer cell line isolated in 1970 from a 69-year-old White woman. MCF-7 is the acronym of Michigan Cancer Foundation-7, referring to the institute in Detroit where the cell line was established in 1973 by Herbert Soule and co-workers. The Michigan Cancer Foundation is now known as the Barbara Ann Karmanos Cancer Institute.
In medicine, desmoplasia is the growth of fibrous connective tissue. It is also called a desmoplastic reaction to emphasize that it is secondary to an insult. Desmoplasia may occur around a neoplasm, causing dense fibrosis around the tumor, or scar tissue (adhesions) within the abdomen after abdominal surgery.
Laminin–111 is a protein of the type known as laminin isoforms. It was among the first of the laminin isoforms to be discovered. The "111" identifies the isoform's chain composition of α1β1γ1. This protein plays an important role in embryonic development. Injections of this substance are used in treatment for Duchenne muscular dystrophy, and its cellular action may potentially become a focus of study in cancer research.
The tumor microenvironment is a complex ecosystem surrounding a tumor, composed of cancer cells, stromal tissue and the extracellular matrix. Mutual interaction between cancer cells and the different components of the tumor microenvironment support its growth and invasion in healthy tissues which correlates with tumor resistance to current treatments and poor prognosis. The tumor microenvironment is in constant change because of the tumor's ability to influence the microenvironment by releasing extracellular signals, promoting tumor angiogenesis and inducing peripheral immune tolerance, while the immune cells in the microenvironment can affect the growth and evolution of cancerous cells.
Susan Band Horwitz is an American biochemist and professor at the Albert Einstein College of Medicine where she holds the Falkenstein chair in Cancer Research as well as co-chair of the department of Molecular Pharmacology.
Joan S. Brugge is the Louise Foote Pfeiffer Professor of Cell Biology and the Director of the Ludwig Center at Harvard Medical School, where she also served as the Chair of the Department of Cell Biology from 2004 to 2014. Her research focuses on cancer biology, and she has been recognized for her explorations into the Rous sarcoma virus, extracellular matrix adhesion, and epithelial tumor progression in breast cancer.
Zena Werb was a professor and the Vice Chair of Anatomy at the University of California, San Francisco. She was also the co-leader of the Cancer, Immunity, and Microenvironment Program at the Hellen Diller Family Comprehensive Cancer Center and a member of the Executive Committee of the Sabre-Sandler Asthma Basic Research Center at UCSF. Her research focused on features of the microenvironment surrounding cells, with particular interest in the extracellular matrix and the role of its protease enzymes in cell signaling.
David Arthur Shirley was an American chemist, best known as the fourth director of the Lawrence Berkeley National Laboratory from 1980 to 1989, and for spearheading the funding and creation of the Advanced Light Source.
Madin-Darby canine kidney (MDCK) cells are a model mammalian cell line used in biomedical research. MDCK cells are used for a wide variety of cell biology studies including cell polarity, cell-cell adhesions, collective cell motility, toxicity studies, as well as responses to growth factors. It is one of few cell culture models that is suited for 3D cell culture and multicellular rearrangements known as branching morphogenesis.
Invasion is the process by which cancer cells directly extend and penetrate into neighboring tissues in cancer. It is generally distinguished from metastasis, which is the spread of cancer cells through the circulatory system or the lymphatic system to more distant locations. Yet, lymphovascular invasion is generally the first step of metastasis.
Shyamala Gopalan was a biomedical scientist at the Lawrence Berkeley National Laboratory, whose work in isolating and characterizing the progesterone receptor gene has stimulated advances in breast biology and oncology. She was the mother of Kamala Harris and Maya Harris, a lawyer and political commentator.
Lydia Lee Sohn is a professor of mechanical engineering and bio-engineering at the University of California, Berkeley and the co-founder of Nodexus. In 2002, Sohn and Paul McEuen uncovered figure duplication and fraud in scientific papers on semiconductors written by Jan Hendrik Schön, leading to multiple retractions and concerns over peer-review, which is referred to as the Schön scandal.
Celeste M. Nelson is a Professor of Chemical and Biological Engineering and the Director of the Program in Engineering Biology at Princeton University. She is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and was a finalist in the 2017 and 2018 Blavatnik Awards for Young Scientists.
Kandice Tanner is a Trinidad and Tobago biophysicist researching the metastatic traits that allow tumor cells to colonize secondary organs. She is a Senior Investigator at the National Cancer Institute, where she is head of the Tissue morphodynamics section.
Esta Sterneck is an Austrian molecular biologist researching the functions of the C/EBPδ][CEBPD transcription factor as tumor suppressor as well as tumor promoter in breast epithelial cells and cells of the tumor microenvironment. She is a senior investigator and head of the molecular mechanisms in development section at the National Cancer Institute.
Cathrin Brisken is a German and Swiss medical doctor, researcher, and professor at the École Polytechnique Fédérale de Lausanne (EPFL). Her research focuses on the mechanisms of hormonal control in breast cancer development.
Andrew Ewald is a professor of cell biology at Johns Hopkins University School of Medicine. He is known for his contributions in the field of metastatic breast cancer research.
Valerie M. Weaver is a professor and the director of the Center for Bioengineering and Tissue Regeneration in the department of surgery and co-director Bay Area Center for Physical Sciences and Oncology at the University of California San Francisco (USA). She has been working and leading oncology research for more than 20 years. Her scientific contributions have been recognised by different awards. She was the first woman to receive the Shu Chien Award from the Biomedical Engineering Society in 2022, which honours contributions in the cellular and molecular bioengineering field.